Great post @JSBStrikesBack. As a side not I would be interested to know peoples thoughts on whether they think the outstanding CMC issues for Rem-L outlined above by the poster is the main reason why the next COVID - ARDS trial has not progressed in any meaningful way that I am aware of with their collaboration partner the NIH (who will also fund it)? I think the NIH will not move forward with the next COVID - ARDS trial until these potency and quality attributes for Rem-L are given a formal tick of approval from OTAT? Would assume things would move forward quickly with the next trial assuming it is still a key focus for Mesoblast.
- Forums
- ASX - By Stock
- BLA resubmission for children with SR-aGVHD
Great post @JSBStrikesBack. As a side not I would be interested...
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.07 |
Change
-0.023(2.05%) |
Mkt cap ! $1.230B |
Open | High | Low | Value | Volume |
$1.09 | $1.09 | $1.07 | $1.236M | 1.145M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 119596 | $1.07 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.08 | 68088 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
26 | 113689 | 1.075 |
21 | 154610 | 1.070 |
14 | 111483 | 1.065 |
15 | 344837 | 1.060 |
9 | 149627 | 1.055 |
Price($) | Vol. | No. |
---|---|---|
1.080 | 27513 | 6 |
1.085 | 108864 | 16 |
1.090 | 119711 | 10 |
1.095 | 82303 | 9 |
1.100 | 96978 | 14 |
Last trade - 11.04am 11/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online